异动解读 | 先声药业脑卒中创新药新剂型获批上市推动股价大涨5.01%

异动解读12-03

先声药业(02096)今日盘中大涨5.01%,引发市场广泛关注。

消息面上,先声药业的脑细胞保护创新药先必新舌下片获得国家药品监督管理局批准上市,用于改善急性缺血性脑卒中所致的神经症状、日常生活活动能力和功能障碍。该药使用了双靶点作用机制,可显著减少卒中导致的脑细胞损伤。

先声药业之前在2020年就已获批上市了先必新注射剂剂型。此次先必新舌下片的获批,将与注射剂形成序贯治疗,有望覆盖卒中全病程,发挥协同效应。根据数据,我国卒中治疗药物市场规模超过1300亿元,且仍保持较快增长,先必新获批上市后有望快速放量。同时,先必新舌下片也计划开展全球多中心临床研究。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1102887225?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-12-03 17:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1102887225","market":"hk","top_or_hot":-1,"title":"异动解读 | 先声药业脑卒中创新药新剂型获批上市推动股价大涨5.01%","media":"异动解读","content":"<p>先声药业(02096)今日盘中大涨5.01%,引发市场广泛关注。</p>\n\n<p>消息面上,先声药业的脑细胞保护创新药先必新舌下片获得国家药品监督管理局批准上市,用于改善急性缺血性脑卒中所致的神经症状、日常生活活动能力和功能障碍。该药使用了双靶点作用机制,可显著减少卒中导致的脑细胞损伤。</p>\n\n<p>先声药业之前在2020年就已获批上市了先必新注射剂剂型。此次先必新舌下片的获批,将与注射剂形成序贯治疗,有望覆盖卒中全病程,发挥协同效应。根据数据,我国卒中治疗药物市场规模超过1300亿元,且仍保持较快增长,先必新获批上市后有望快速放量。同时,先必新舌下片也计划开展全球多中心临床研究。</p>","source":"ai_movement_cn","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>异动解读 | 先声药业脑卒中创新药新剂型获批上市推动股价大涨5.01%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n异动解读 | 先声药业脑卒中创新药新剂型获批上市推动股价大涨5.01%\n</h2>\n\n<h4 class=\"meta\">\n\n2024-12-03 17:26 北京时间&nbsp;&nbsp;&nbsp;<strong>异动解读</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>先声药业(02096)今日盘中大涨5.01%,引发市场广泛关注。\n消息面上,先声药业的脑细胞保护创新药先必新舌下片获得国家药品监督管理局批准上市,用于改善急性缺血性脑卒中所致的神经症状、日常生活活动能力和功能障碍。该药使用了双靶点作用机制,可显著减少卒中导致的脑细胞损伤。\n先声药业之前在2020年就已获批上市了先必新注射剂剂型。此次先必新舌下片的获批,将与注射剂形成序贯治疗,有望覆盖卒中全病程,...</p>\n\n<a href=\"\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02096","symbol_name":"先声药业","start_time":0,"source_url":"","article_id":"1102887225","we_media_id":"1092702339","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1102887225","pubTimestamp":1733217997,"columns":[],"sourceInfo":{"source_id":"ai_movement_cn","name":"异动解读"},"weMediaInfo":{"media_name":"异动解读","introduction":"个股异动一手消息解读","home_visible":1,"id":"1092702339","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"先声药业(02096)今日盘中大涨5.01%,引发市场广泛关注。\n\n消息面上,先声药业的脑细胞保护创新药先必新舌下片获得国家药品监督管理局批准上市,用于改善急性缺血性脑卒中所致的神经症状、日常生活活动能力和功能障碍。该药使用了双靶点作用机制,可显著减少卒中导致的脑细胞损伤。\n\n先声药业之前在2020年就已获批上市了先必新注射剂剂型。此次先必新舌下片的获批,将与注射剂形成序贯治疗,有望覆盖卒中全病程,发挥协同效应。根据数据,我国卒中治疗药物市场规模超过1300亿元,且仍保持较快增长,先必新获批上市后有望快速放量。同时,先必新舌下片也计划开展全球多中心临床研究。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"02096":"先声药业"},"translate_title":"Interpretation of changes: Simcere Pharmaceuticals' new dosage form of innovative stroke drug was approved for listing, pushing the stock price up 5.01%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02096":1},"content_text":"先声药业(02096)今日盘中大涨5.01%,引发市场广泛关注。\n消息面上,先声药业的脑细胞保护创新药先必新舌下片获得国家药品监督管理局批准上市,用于改善急性缺血性脑卒中所致的神经症状、日常生活活动能力和功能障碍。该药使用了双靶点作用机制,可显著减少卒中导致的脑细胞损伤。\n先声药业之前在2020年就已获批上市了先必新注射剂剂型。此次先必新舌下片的获批,将与注射剂形成序贯治疗,有望覆盖卒中全病程,发挥协同效应。根据数据,我国卒中治疗药物市场规模超过1300亿元,且仍保持较快增长,先必新获批上市后有望快速放量。同时,先必新舌下片也计划开展全球多中心临床研究。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1102887225"}